Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Oct 2026
At CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment.
Read Full NewsOmid Pourshahid, MD, MPH, discusses Medicare coverage for virtual pulmonary rehab and a matched-care pathway for center-based, hybrid, or virtual programs.
Experts Examine Biologic Coverage in Asthma and COPD
Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives
Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD
Data from the real-world, CONFIDENCE study found switching from intravenous to subcutaneous ocrelizumab was well tolerated in patients with relapsing and primary progressive MS.
The phase 2 FENerations1 study is an open-label, single-arm, small-scale study evaluating fenebrutinib dosing in 8 to 12 children and adolescents with relapsing MS.
A phase 2 trial found liposomal mitoxantrone hydrochloride had an acceptable safety profile and a potential trend toward fewer relapses in neuromyelitis optica spectrum disorder.
1.
Adipocytes in the bone marrow offer early indicators of the development of multiple myeloma from MGUS.
2.
Researchers explore e-bikes for cancer recovery
3.
Acupuncture may alleviate nocturia in men treated for prostate cancer
4.
Watch for Psoriasis After Cancer Immunotherapy, Study Says
5.
Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.
1.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
2.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
3.
Quality of Life Following Functional Hematopoietic Recovery
4.
Intracellular Nanobody Therapeutics: Mechanisms, Clinical Relevance, and Emerging Applications
5.
Beyond Driver Mutations: Context-Dependent Synthetic Lethality as the Next Frontier of Precision Oncology
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Emerging Concepts in Hematology
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
4.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
5.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge